Pharmacokinetic and pharmacodynamic studies of iloperidone-loaded lipid nanoemulsions via oral route of administration

References

• Citrome L. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion. Expert Opin Drug Metab Toxicol. 2010;6(12):1551–1564.
   PubMed Web of Science ®Google Scholar
• Londhe V, Shirsat R. Formulation and characterization of fast-dissolving sublingual film of iloperidone using Box–Behnken design for enhancement of oral bioavailability. AAPS PharmSciTech. 2018;19(3):1392–1400.
   PubMed Web of Science ®Google Scholar
• Mandpe L, Pokharkar V. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement. Pharm Dev Technol. 2015;20(3):320–329.
   PubMed Web of Science ®Google Scholar
• Zhang TT, Wang HT, Jia JT, et al. Syntheses and pharmacokinetics properties of an iloperidone pharmaceutical cocrystal. Inorg Chem Commun. 2014;39:144–146.
   Web of Science ®Google Scholar
• Dinesh S, Arjun N, Kishan V. Development, characterization, comparative pharmacokinetic and pharmacodynamic studies of iloperidone solid SMEDDS and liquisolid compact. Drug Dev Ind Pharm. 2020;46(4):587–596.
   Google Scholar
• Karl H, Drug AZ. delivery and drug targeting with parenteral lipid nanoemulsions – a review. J Control Release. 2016;223:85–98.
   PubMed Web of Science ®Google Scholar
• Takino T, Konishi K, Takakura Y, et al. Long circulating emulsion carrier systems for highly lipophilic drugs. Biol Pharm Bull. 1994;17(1):121–125.
   PubMed Web of Science ®Google Scholar
• Floyd AG. Top ten considerations in the development of parenteral emulsions. Pharm Sci Technol Today. 1999;4(2):134–143.
   PubMedGoogle Scholar
• Singh Y, Meher JG, Raval K, et al. Nanoemulsion: concepts, development and applications in drug delivery. J Control Release. 2017;252:28–49.
   PubMed Web of Science ®Google Scholar
• Mizushima Y. Lipid microspheres (lipid emulsions) as a drug carrier—an overview. Adv Drug Deliv Rev. 1996;20(2-3):113–115.
   Web of Science ®Google Scholar
• Singh M, Ravin LJ. Parenteral emulsions as drug carrier systems. J Parenter Sci Technol. 1986;40(1):34–41.
   PubMedGoogle Scholar
• Swapna M, Muzammil Afzal S, Prabhakar K, et al. Cationic diclofenac lipid nanoemulsions for improved oral bioavailability: preparation, characterization and in vivo evaluation. Int J Pharm Sci Nanotechnol. 2015; 8(2)2874–2880.
   Google Scholar
• Narala A, Guda S, Veerabrahma K. Lipid nanoemulsions of rebamipide: formulation, characterization, and in vivo evaluation of pharmacokinetic and pharmacodynamic effects. AAPS PharmSciTech. 2019;20(1):26.
   PubMed Web of Science ®Google Scholar
• Varshika E, Prabakar K, Kishan V. Preparation, characterization and in vivo pharmacodynamic evaluation of parenteral diclofenac submicron lipid emulsions. PDA. J Pharm Sci Tech. 2009;63(5):380–389.
   Google Scholar
• Gettings SD, Lordo RA, Feder PI, et al. A comparison of low volume, draize and in vitro eye irritation test data. II. Oil/water emulsions. Food Chem Toxicol. 1998;36(1):47–59.
   PubMed Web of Science ®Google Scholar
• Muzammil Afzal S, Kishan V. Preparation, characterization and in vitro evaluation of stealth docetaxel lipid nanoemulsions for efficient cytotoxicity. Int J Drug Deliv. 2013;5:188–195.
   Google Scholar
• Prabhakar K, Muzammil Afzal S, S, Kishan V. Brain specific delivery of pegylated indinavir submicron lipid emulsions. Eur J Pharm Sci. 2011;42:423–432.
   PubMed Web of Science ®Google Scholar
• Syed MA, Zubair MS, Dinesh T, et al. Folate-PEG-decorated docetaxel lipid nanoemulsion for improved antitumor activity. Nanomedicine. 2016;11(16):2171–2110.
   PubMed Web of Science ®Google Scholar
• Syed MA, Zubair MS, Kishan V. Transferrin tagged lipid nanoemulsion of docetaxol for enhanced tumour targetting. J Drug Deliv Sci Tec. 2016;36:175–182.
   Web of Science ®Google Scholar
• Prabhakar K, Muzammil Afzal S, Surendar G, et al. Albumin coupled lipid nanoemulsions of diclofenac for targeted delivery to inflammation. Nanomed: Nanotechnol Biol Med. 2012;8:1162–1171.
   PubMed Web of Science ®Google Scholar
• Muzammil Afzal S, Naidu VG, Harishankar N, et al. Albumin anchored docetaxel lipid nanoemulsion for improved targeting efficiency – preparation, characterization, cytotoxic, antitumor and in vivo imaging studies. Drug Deliv. 2016;23(4):1355–1363.
   PubMed Web of Science ®Google Scholar
• Prabhakar K, Afzal SM, Surender G, et al. Tween 80 coated nanoemulsions for delivery of indinavir to brain. Acta Pharmaceutica Sinica B. 2013;3(5):345–353.
   Web of Science ®Google Scholar
• Ganta S, Talekar M, Singh A, et al. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy. AAPS PharmSciTech. 2014;15(3):694–708.
   PubMed Web of Science ®Google Scholar
• Narendar D, Kishan V. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv. 2014;23(2):395–404.
   PubMed Web of Science ®Google Scholar
• Narendar D, Kishan V. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design. Drug Dev Ind Pharm. 2015;41(12):1968–1977.
   PubMed Web of Science ®Google Scholar
• Venu Madhav K, Kishan V. Improvement of anti-hyperlipidemic activity and oral bioavailability of fluvastatin via solid self-microemulsifying systems and comparative with liquisolid formulation. Curr Drug Deliv. 2018;15(9):1245–1260.
   PubMed Web of Science ®Google Scholar
• Srividya R, Prabhakar K, Kishan V. Formulation and pharmacokinetics of diclofenac lipid nanoemulsions for parenteral application. PDA J Pharm Sci Technol. 2012;66(1):28–37.
   Google Scholar
• Swetha B, Prabhakar K, Apte SS, et al. Development of indinavir submicron lipid emulsions loaded with lipoamino acids-in vivo pharmacokinetics and brain-specific delivery. AAPS PharmSciTech. 2011;12(1):422–430.
   PubMed Web of Science ®Google Scholar
• Mandpe L, Kyadarkunte A, Pokharkar V. High-performance liquid chromatographic method for simultaneous determination of iloperidone and idebenone in spiked plasma. Int J Chem Anal Sci. 2013;4(1):19–23.
   Google Scholar
• Su YA, Si TM, Zhou DF, et al. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors. Eur J Pharmacol. 2007;564(1-3):123–130.
   PubMed Web of Science ®Google Scholar
• Bhosale UA, Yegnanarayan R, Pophale PD, et al. Study of central nervous system depressant and behavioral activity of an ethanol extract of Achyranthes aspera (Agadha) in different animal models. Int J App Basic Med Res. 2011;1(2):104–108.
   PubMedGoogle Scholar